Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 08:08 am Purchase | 2020-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,850,000 6.400% | 2,850,000 (New Position) | Filing History |
| 2021-02-12 08:08 am Purchase | 2020-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA | Avoro Capital Advisors LLC | 4,190,000 7.200% | 4,190,000 (New Position) | Filing History |
| 2021-02-12 08:07 am Purchase | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | Avoro Capital Advisors LLC | 4,365,000 7.500% | 4,365,000 (New Position) | Filing History |
| 2021-02-12 08:06 am Purchase | 2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,225,000 7.900% | 1,225,000 (New Position) | Filing History |
| 2021-02-12 08:06 am Purchase | 2020-12-31 | 13G | IVERIC bio, Inc. ISEE | Avoro Capital Advisors LLC | 7,250,000 8.100% | 7,250,000 (New Position) | Filing History |
| 2021-02-12 08:05 am Purchase | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Avoro Capital Advisors LLC | 1,525,000 9.400% | 1,525,000 (New Position) | Filing History |
| 2021-02-12 08:04 am Purchase | 2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | Avoro Capital Advisors LLC | 272,000 9.900% | 272,000 (New Position) | Filing History |
| 2021-02-12 08:04 am Purchase | 2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA | Avoro Capital Advisors LLC | 33,613,444 9.990% | 33,613,444 (New Position) | Filing History |
| 2021-02-12 08:03 am Sale | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Avoro Capital Advisors LLC | 7,500,000 5.100% | -1,326,039 (-15.02%) | Filing History |
| 2021-02-12 08:01 am Sale | 2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | Avoro Capital Advisors LLC | 2,950,000 6.200% | -700,000 (-19.18%) | Filing History |
| 2021-02-12 08:01 am Purchase | 2020-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Avoro Capital Advisors LLC | 1,670,000 6.500% | 564,001 (+50.99%) | Filing History |
| 2021-02-12 08:00 am Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Avoro Capital Advisors LLC | 800,000 8.200% | 275,000 (+52.38%) | Filing History |
| 2021-02-12 08:00 am Purchase | 2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Avoro Capital Advisors LLC | 4,535,000 9.020% | 621,565 (+15.88%) | Filing History |
| 2020-10-23 5:25 pm Sale | 2020-10-23 | 13D | IMMUNOMEDICS INC IMMU | Avoro Capital Advisors LLC | 0 0.000% | -21,000,000 (Position Closed) | Filing History |